Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000635009 | SCV000756387 | likely benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-04-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004704145 | SCV005216891 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004965613 | SCV005552816 | uncertain significance | Inborn genetic diseases | 2024-07-17 | criteria provided, single submitter | clinical testing | The c.5825C>T (p.A1942V) alteration is located in exon 33 (coding exon 32) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 5825, causing the alanine (A) at amino acid position 1942 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |